Equities Analysts Offer Predictions for Indaptus Therapeutics, Inc.'s FY2023 Earnings (NASDAQ:INDP)

Indaptus Therapeutics, Inc. (NASDAQ:INDP – Free Report) – Analysts at HC Wainwright increased their FY2023 earnings estimates for shares of Indaptus Therapeutics in a research report issued on Tuesday, November 7th. HC Wainwright analyst R. Selvaraju now expects that the company will earn ($1.90) per share for the year, up from their previous estimate of […]

Related Keywords

Glenr Anderson , ,Investment House ,Northern Trust Corp ,Nasdaq ,Vanguard Group Inc ,Indaptus Therapeutics Company Profile ,Renaissance Technologies ,Indaptus Therapeutics Inc ,Indaptus Therapeutics ,Free Report ,Indaptus Therapeutic ,Get Free Report ,Trust Corp ,Street Corp ,Indaptus Therapeutics Daily ,Nasdaq Indp ,Findp ,Medical ,Earnings Estimates ,Hc Wainwright ,